(0.32%) 5 116.17 points
(0.38%) 38 386 points
(0.35%) 15 983 points
(-1.31%) $82.75
(6.40%) $2.05
(0.06%) $2 348.50
(-0.30%) $27.45
(4.13%) $960.20
(-0.20%) $0.933
(-0.37%) $10.98
(-0.53%) $0.796
(1.66%) $93.40
-0.55% INR 4 883.50
Live Chart Being Loaded With Signals
Alkem Laboratories Limited, a pharmaceutical company, engages in the development, manufacture, and sale of pharmaceutical and nutraceutical products in India and internationally...
Stats | |
---|---|
Dagens volum | 140 497 |
Gjennomsnittsvolum | 257 805 |
Markedsverdi | 583.90B |
EPS | INR49.76 ( 2024-02-09 ) |
Neste inntjeningsdato | ( INR0 ) 2024-05-16 |
Last Dividend | INR10.00 ( 2023-08-09 ) |
Next Dividend | INR0 ( N/A ) |
P/E | 37.11 |
ATR14 | INR5.77 (0.12%) |
Volum Korrelasjon
Alkem Laboratories Korrelasjon
10 Mest positive korrelasjoner | |
---|---|
MASPTOP50.NS | 0.902 |
MAFANG.NS | 0.885 |
BAJAJ-AUTO.NS | 0.881 |
HARIOMPIPE.NS | 0.876 |
MON100.NS | 0.869 |
SETF10GILT.NS | 0.868 |
DATAPATTNS.NS | 0.868 |
MANINDS.NS | 0.865 |
MOGSEC.NS | 0.862 |
GTNTEX.NS | 0.861 |
10 Mest negative korrelasjoner | |
---|---|
MOHOTAIND.NS | -0.877 |
ROLTA.NS | -0.865 |
SECURKLOUD.NS | -0.864 |
SUMICHEM.NS | -0.861 |
RUSHIL.NS | -0.852 |
CLNINDIA.NS | -0.849 |
BAFNAPH.NS | -0.848 |
LICI.NS | -0.847 |
DPSCLTD.NS | -0.846 |
EASTSILK.NS | -0.841 |
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Alkem Laboratories Korrelasjon - Valuta/Råvare
Alkem Laboratories Økonomi
Annual | 2022 |
Omsetning: | INR115.99B |
Bruttogevinst: | INR66.92B (57.70 %) |
EPS: | INR82.31 |
FY | 2022 |
Omsetning: | INR115.99B |
Bruttogevinst: | INR66.92B (57.70 %) |
EPS: | INR82.31 |
FY | 2022 |
Omsetning: | INR105.12B |
Bruttogevinst: | INR62.29B (59.25 %) |
EPS: | INR137.63 |
FY | 2021 |
Omsetning: | INR87.47B |
Bruttogevinst: | INR51.61B (59.00 %) |
EPS: | INR132.57 |
Financial Reports:
No articles found.
Alkem Laboratories Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
INR4.00 (N/A) |
INR0 (N/A) |
INR25.00 (N/A) |
INR0 (N/A) |
INR10.00 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | INR9.70 | 2016-03-18 |
Last Dividend | INR10.00 | 2023-08-09 |
Next Dividend | INR0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 15 | -- |
Total Paid Out | INR177.70 | -- |
Avg. Dividend % Per Year | 0.71% | -- |
Score | 2.85 | -- |
Div. Sustainability Score | 3.90 | |
Div.Growth Potential Score | 5.50 | |
Div. Directional Score | 4.70 | -- |
Year | Amount | Yield |
---|---|---|
2016 | INR0 | 0.00% |
2017 | INR0 | 0.00% |
2018 | INR13.00 | 0.65% |
2019 | INR16.00 | 0.83% |
2020 | INR25.00 | 1.20% |
2021 | INR30.00 | 1.02% |
2022 | INR34.00 | 0.93% |
2023 | INR35.00 | 1.17% |
2024 | INR0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
SIYSIL.NS | Dividend Junior | 2023-07-24 | Semi-Annually | 18 | 1.37% | |
MEDICAMEQ.NS | Ex Dividend Junior | 2023-09-20 | Annually | 3 | 0.02% | |
GULFOILLUB.NS | Dividend Junior | 2023-08-25 | Annually | 11 | 2.19% | |
BBTC.NS | Dividend Junior | 2023-09-22 | Annually | 22 | 0.08% | |
PRESTIGE.NS | Dividend Junior | 2023-09-14 | Annually | 14 | 0.25% | |
KANSAINER.NS | Dividend Junior | 2023-05-25 | Annually | 21 | 0.49% | |
EIHAHOTELS.NS | Dividend Junior | 2023-07-31 | Sporadic | 17 | 0.31% | |
ADVENZYMES.NS | Dividend Junior | 2023-08-04 | Annually | 8 | 0.59% | |
SUBROS.NS | Dividend Junior | 2023-08-22 | Annually | 20 | 0.22% | |
NAHARSPING.NS | Dividend Junior | 2023-09-08 | Annually | 18 | 0.74% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.125 | 1.500 | 7.51 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0 | 1.200 | 0 | 0 | [0 - 0.3] |
returnOnEquityTTM | 0.163 | 1.500 | 9.30 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0 | 0.800 | -5.00 | -4.00 | [1 - 3] |
quickRatioTTM | 0 | 0.800 | -4.71 | -3.76 | [0.8 - 2.5] |
cashRatioTTM | 0 | 1.500 | -1.111 | -1.667 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 18.58 | 1.000 | 4.23 | 4.23 | [3 - 30] |
operatingCashFlowPerShareTTM | 49.21 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 49.21 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.597 | 1.000 | 3.38 | 3.38 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.168 | 1.000 | 8.63 | 8.63 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 0 | 0.800 | -3.33 | -2.67 | [0.5 - 2] |
Total Score | 3.90 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 37.72 | 1.000 | 6.29 | 0 | [1 - 100] |
returnOnEquityTTM | 0.163 | 2.50 | 9.55 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 49.21 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0.907 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 49.21 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 9.88 | 1.500 | 10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0466 | 1.000 | -1.336 | 0 | [0.1 - 0.5] |
Total Score | 5.50 |
Alkem Laboratories
Alkem Laboratories Limited, a pharmaceutical company, engages in the development, manufacture, and sale of pharmaceutical and nutraceutical products in India and internationally. The company offers branded generics, generic drugs, active pharmaceutical ingredients, biosimilars, and nutraceuticals in acute and chronic therapeutic areas comprising anti-infective, dermatology, cardiac, respiratory, gastro-intestinal, central nervous system, oncology, urology, and gynaecology, as well as vitamins, minerals, and nutrients; and pain analgesic, anti-diabetic, and neurology products. It also provides pregnancy detection kits and condoms. The company was incorporated in 1973 and is headquartered in Mumbai, India.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.